When Dr. Patel meets with patients and their families, he walks them step-by-step through the treatment plan and ensures that they receive the most-effective surgery, when that is the best approach for the patient.

Dr. Bochner – who specializes in treating people with prostate, bladder, and kidney cancers – discusses the importance of a multidisciplinary team approach to delivering high-quality care.

A team from Memorial Sloan-Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.

Problems with cognitive function can significantly impact a person’s quality of life after cancer treatment. New research is focused on the link between cancer treatment and cognitive changes.

Memorial Sloan-Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Memorial Sloan-Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma.

Study signals hope for maintaining sexual function in men undergoing radiation treatment for prostate cancer.